Prosecution Insights
Last updated: October 25, 2026

Cozen O'Connor-Dc Office

Technology areas: Biotechnology & Pharmaceuticals • Communications • Medical Devices & Mechanical Engineering

5 pending office actions • 4 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Cozen O'Connor-DC Office handles Biotechnology & Pharmaceuticals matters. The profile includes 6 pending office actions and 19456 career applications, showing a limited current docket within a broad historical application record.

The resolved allowance rate is 85.66%, with an average of 3.35 office actions per allowance. The record indicates frequent allowance among resolved matters, while also suggesting that several examination exchanges may precede that result. Practitioners should use the figures for portfolio context and assess each biotechnology matter independently.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=19456 apps, methodology: how we score firms)

85.7%
Allowance Rate
n=19456
+0.54σ
Allowance Rate (norm)
n=19456
3.4
OAs to Allowance
n=12817
-0.03σ
OAs to Allow (norm)
n=12817
1067 days
Time to Allowance
n=12817
+4.9pp
Interview Lift
n=19456
24.9%
RCE Rate
n=19456
2.2%
Appeal Rate
n=19456

Rejection Performance (% of received rejections ultimately overcome)

77.7%
§101 Overcome
n=1370
78.5%
§102 Overcome
n=5625
80.2%
§103 Overcome
n=8950
82.4%
§112 Overcome
n=5891

Specialization & Scale

H04W, H04L, G06F
Top CPC Subclasses
11%
Top-3 CPC Share
n=19456
0
Practitioners
n=19456
—
Apps / Practitioner
n=19456 (min 20)

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
1
Medium (20%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only1 (20%)
§112 only1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
40% of docket
0
Information Tech
0% of docket
1
Communications
20% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NOAKES, SUZANNE MARIE 1 73.4% +18.3%
GREENLUND, JOSEPH A 1 66.8% +33.8%
JANG, CHRISTIAN Y 1 68.7% +21.0%
MUNION, JAMES E 1 77.4% +22.9%
HINES, JANA A 1 53.2% +39.4%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19069321 SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF NOAKES, SUZANNE MARIE 66d overdue
18561817 DISINFECTION COMPOSITION HINES, JANA A 37d overdue
18994819 DEVICE FOR EVAPORATING VOLATILE SUBSTANCES GREENLUND, JOSEPH A —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19069321 SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF NOAKES, SUZANNE MARIE 66d overdue
18561817 DISINFECTION COMPOSITION HINES, JANA A 37d overdue
18994819 DEVICE FOR EVAPORATING VOLATILE SUBSTANCES GREENLUND, JOSEPH A —
18846979 METHOD FOR PROVIDING FETUS MONITORING SERVICE AND SERVER FOR PERFORMING SAME JANG, CHRISTIAN Y —
18750163 DUAL-TECHNOLOGY ELECTRONIC SEAL WITH INTEGRITY MONITORING SYSTEM AND INTEGRITY MONITORING METHOD OF SAID SEAL MUNION, JAMES E —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
16561
37521
37911
26881
16451

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19069321 SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF Zhenglong Sun NOAKES, SUZANNE MARIE 1656 §102§112 Non-Final OA 66d overdue Pending Mar 04, 2025
18994819 DEVICE FOR EVAPORATING VOLATILE SUBSTANCES ZOBELE HOLDING S.P.A. GREENLUND, JOSEPH A 3752 §102§112 Non-Final OA — Pending Jan 15, 2025
18846979 METHOD FOR PROVIDING FETUS MONITORING SERVICE AND SERVER FOR PERFORMING SAME Sungkwang Medical Foundation JANG, CHRISTIAN Y 3791 §112 Final Rejection — Pending Sep 13, 2024
18750163 DUAL-TECHNOLOGY ELECTRONIC SEAL WITH INTEGRITY MONITORING SYSTEM AND INTEGRITY MONITORING METHOD OF SAID SEAL Monitainer Tecnologia E Serviços Ltda MUNION, JAMES E 2688 §103 Non-Final OA — Pending Jun 21, 2024
18561817 DISINFECTION COMPOSITION ZOBELE HOLDING S.P.A. HINES, JANA A 1645 §101§102§103 Final Rejection 37d overdue Pending Nov 17, 2023

Managing Cozen O'Connor-Dc Office's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Cozen O'Connor-Dc Office's patent allowance rate?

85.7% of resolved applications prosecuted by Cozen O'Connor-Dc Office were allowed, across 19,456 applications in USPTO records.

How many office actions does Cozen O'Connor-Dc Office average before allowance?

3.35 office actions per allowed application on average.

How many pending office actions does Cozen O'Connor-Dc Office have?

5 pending office actions as of October 2026, for 4 clients, before 5 examiners in 5 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month